Increase in body weight was observed in more than 50% of schizophrenic patients who
receive antipsychotic drugs in general. 8 Body mass index (BMI) is significantly higher in …

CONTEXTO: Após cinco décadas de síntese e disseminação de uso de drogas para o
tratamento da esquizofrenia, foi possível observar a disponibilidade de drogas com …

Objective: Patients with schizophrenia treated with clozapine often gain weight. This study
evaluated the effects of dietary control and physical activity among obese inpatients with …

Objective Clozapine is the first choice in drug-resistant schizophrenia but also causes
important weight changes. This might discourage clinicians who are concerned about the …

OBJETIVO: Avaliar o estado nutricional de pacientes com esquizofrenia, atendidos por um
programa de reabilitação social (CAPS). MÉTODOS: Foi realizado um estudo transversal …

A number of studies have reported that patients with schizophrenia have a higher body
mass index (BMI) than the general population. Few Asian studies have examined BMI in …

The aim of the present study was to investigate the relationship between 10 psychotropic
agents and worsening BMI from overweight to obesity among inpatients with schizophrenia …

The prevalence of obesity in inpatients of a German psychiatric rehabilitation center for
adolescents and young adults (mean age 19.5 years) is assessed and set into relationship …

Objective: To evaluate the distributions of body mass index in a large sample of patients with
schizophrenia, and to examine the association between body weight and antipsychotic …

Background Obesity seems to be very frequent among schizophrenics, partly due to
psychotropic medications. To examine this possibility the authors compared the distribution …